Article Versions Notes

Kubacka M, Nowak B, Zadrożna M, Szafarz M, Latacz G, Marona H, Sapa J, Mogilski S, Bednarski M, Kotańska M. Manifestations of Liver Impairment and the Effects of MH-76, a Non-Quinazoline α1-Adrenoceptor Antagonist, and Prazosin on Liver Tissue in Fructose-Induced Metabolic Syndrome. Metabolites. 2023; 13(11):1130. https://doi.org/10.3390/metabo13111130

Kubacka, Monika, Barbara Nowak, Monika Zadrożna, Małgorzata Szafarz, Gniewomir Latacz, Henryk Marona, Jacek Sapa, Szczepan Mogilski, Marek Bednarski, and Magdalena Kotańska. 2023. "Manifestations of Liver Impairment and the Effects of MH-76, a Non-Quinazoline α1-Adrenoceptor Antagonist, and Prazosin on Liver Tissue in Fructose-Induced Metabolic Syndrome" Metabolites 13, no. 11: 1130. https://doi.org/10.3390/metabo13111130

Kubacka, M., Nowak, B., Zadrożna, M., Szafarz, M., Latacz, G., Marona, H., Sapa, J., Mogilski, S., Bednarski, M., & Kotańska, M. (2023). Manifestations of Liver Impairment and the Effects of MH-76, a Non-Quinazoline α1-Adrenoceptor Antagonist, and Prazosin on Liver Tissue in Fructose-Induced Metabolic Syndrome. Metabolites, 13(11), 1130. https://doi.org/10.3390/metabo13111130